吲哚菁绿近红外荧光显像技术在肝细胞癌肝切除术中的应用价值

Application of indocyanine green near infrared fluorescence imaging in the surgical treatment of hepatocellular carcinoma

  • 摘要: 目的:探讨吲哚菁绿近红外荧光显像技术在肝细胞癌肝切除术中的临床应用价值。 方法 采用前瞻性研究方法。收集2014年10月至2015年2月解放军总医院临床诊断为肝细胞癌预行肝切除术 24例患者的临床病理资料。术前(20.0~120.0 h,平均47.5 h)给予静脉注射吲哚菁绿(0.5 mg/kg)。开腹暴露并游离肝脏后,手持荧光检测仪器探头,实时可视化显示肿瘤,并引导肿瘤完整切除后,继续对在体剩余肝脏尤其是切缘周围进行探测,将所有疑似病灶进行术中快速冷冻切片病理学检查。对离体肿瘤标本剖面进行荧光成像,结合病理学检查结果进行分析。观察指标:(1)术前发现肿瘤的荧光显像检查情况。(2)荧光显像检查发现新病灶情况。(3)离体标本肿瘤剖面荧光显像特点。(4)随访情况。采用电话或门诊随访,术后随访1年,每3个月复查一次增强CT及相关实验室检查,记录患者复发率和病死率。随访时间截至2015年10月。正态分布的计量资料采用平均数(范围)表示。
    结果:(1)术前发现肿瘤的荧光显像检查情况:24例患者术前影像学检查发现24个肿瘤。其中能够在体肝脏表面肿瘤相应投射区域呈现荧光19个;肿瘤平均深度为0.36 cm(0.00~0.65 cm),平均直径为6.20 cm(1.20~9.00 cm)。未显现荧光 5个,肿瘤平均深度为1.52 cm(0.90~2.60 cm),平均直径为4.60 cm(1.50~7.80 cm)。(2)荧光显像检查发现新发病灶情况:24例患者共发现新的疑似病灶13个,病灶平均深度为0.30 cm(0.00~0.60 cm),平均直径为0.65 cm(0.20~1.20 cm),术中快速冷冻切片病理学检查结果证实为肝硬化结节4个、癌3个(高分化1个、中分化2个)、异型增生2个、肝组织炎性改变2个、肝细胞脂肪变性2个。(3)离体标本肿瘤剖面荧光显像特点:24例患者的离体标本肿瘤中央剖开,探测剖面均显示很强的荧光。其中 11个高分化肝癌均为肿瘤实质显像,而9个中分化肝癌中有2个属于肿瘤实质显像,7个为肿瘤周围肝组织环状显像,其他4例低分化肝癌则均属于肿瘤周围肝组织显像。(4)随访情况:术后24例患者随访1年,无死亡病例,其中3例患者肿瘤复发,平均复发时间为8.3个月(5.0~11.0个月)。复发患者均进行以外科治疗为主的综合治疗。
    结论:吲哚菁绿介导近红外荧光显像技术能够在术中显示原发肿瘤部位,同时可探测到术前常规影像检查和术中视、触诊漏检的微小病灶,在提供术中肿瘤准确定位的同时,有助于肿瘤的彻底清除。

     

    Abstract: Objective:To investigate the clinical application of indocyanine green (ICG) near infrared fluorescence imaging in the surgical treatment of hepatocellular carcinoma (HCC).
    MethodThe prospective study was adopted. The clinicopathologic data of 24 patients with HCC who underwent surgical resection at the General Hospital of PLA from October 2014 to February 2015 were collected. Intravenous injection of ICG (0.5 mg/kg) was performed before surgery (range, 20.0-120.0 hours, mean, 47.5 hours). After free liver in open surgery, tumor lesions were displayed by fluorescent detector probe and completely resected under the guidance of the probe. The residual liver in vivo was detected, especially resection margin, and rapid frozen pathological examination of suspected lesions were conducted during operation. Fluorescence imaging of isolated tumor specimens was performed, the results of which were analyzed with results of pathological examination. Fluorescence imaging characteristics of the preoperative tumor, new lesions and isolated tumor specimens were observed. The followup using outpatient examination and telephone interview was performed for 1 year up to October 2015. The enhanced rescan of computed tomography (CT) and laboratory reexamination were performed every 3 months, and recurrence rate and mortality were recorded. Measurement data with normal distribution were represented as average (range).
    Result: (1) Twentyfour primary lesions in 24 patients were detected by preoperative imaging examination. Of the 24 primary lesions, 19 showed fluoresce on the liver surface with an average depth of 0.36 cm (range, 0.00-0.65 cm) and an average diameter of 6.20 cm (range,1.20-9.00 cm), 5 didn't show fluoresce with an average depth of 1.52 cm (range, 0.90-2.60 cm) and an average diameter of 4.60 cm (range, 1.50-7.80 cm). (2) Thirteen new suspicious lesions were detected in the residual liver, with an average depth of 0.30 cm (range, 0.00-0.60 cm) and an average diameter of 0.65 cm (range, 0.20- 1.20 cm). The results of intraoperative rapid frozen pathological examination showed that cirrhotic liver nodule was diagnosed in 4 patients, cancer in 3 patients (1 with highdifferentiated tumor and 2 with moderatedifferentiated tumor), dysplasia in 2 patients, inflammatory changes in 2 patients and fatty degeneration in 2 patients. (3) Isolated tumor specimens from 24 patients were cut along the center, with strong fluoresce on the sections. Eleven highdifferentiated tumors showed tumor tissue imaging, 2 of 9 moderatedifferentiated tumors showed tumor tissue imaging and 7 of 9 moderatedifferentiated tumors showed annular fluorescent imaging of tumor peripheral tissue, 4 poordifferentiated tumors showed annular fluorescent imaging of tumor peripheral tissue. (4) All the 24 patients were followed up for 1 year without death, and 3 of 24 patients had tumor recurrences with an average recurrence time of 8.3 months (range, 5.0-11.0 months) and received comprehensive treatment as the main treatment of surgery.
    Conclution: ICG mediated near infrared fluorescence imaging during the surgery can not only display the primary tumor location clearly, but also detect small lesions which are invisible by routine preoperative imaging examination or during operation, with an advantage of complete tumor clearance.

     

/

返回文章
返回